Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 3/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.49 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.49 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30866550 | 1.00 | CHRM2 (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL11285450 | 1.00 | CHRM2 (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL31019614 | 1.00 | CHRM2 (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Acetic Acid SCHEMBL27199886 | 0.91 | CHRNB2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| L-Lactic Acid SCHEMBL27199933 | 0.87 | BLM (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Lactic Acid SCHEMBL27199929 | 0.87 | BLM (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Cadaverine Tartrate SCHEMBL30866575 | 0.87 | BLM (0.54) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Benzoic Acid SCHEMBL27199864 | 0.85 | CHRNB2 (0.44) | CHRNB2CHRNB4CHRNA3CHRNA7CHRNA4 | |
| SCHEMBL28648006 | 0.85 | CHRNB2 (0.45) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Levulinic Acid SCHEMBL27199881 | 0.83 | CHRNB2 (0.37) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2024-04-23 | — | — | US | claimed |
| EP-0000106-B1 | 2-ALKYL NICOTINOIDS AND PROCESSES FOR THEIR PRODUCTION AND USE | PHILIP MORRIS INCORPORATED (US) | 1982-02-17 | — | — | EP | claimed |
| US-4155909-A | INSECTICIDES | PHILIP MORRIS INCORPORATED (US) | 1979-05-22 | — | — | US | claimed |
| EP-0000106-A1 | 2-Alkyl nicotinoids and processes for their production and use | PHILIP MORRIS INCORPORATED (US) | 1978-12-20 | — | — | EP | claimed |
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | Ready Mix Naturals, LLC (US) | 2024-04-23 | — | — | US | disclosed |
| EP-0000106-B1 | 2-ALKYL NICOTINOIDS AND PROCESSES FOR THEIR PRODUCTION AND USE | PHILIP MORRIS INCORPORATED (US) | 1982-02-17 | — | — | EP | disclosed |
| US-4220781-A | QUARTINIZATION, REARRANGEMENT AND REDUCTION | PHILIP MORRIS, INC. (US) | 1980-09-02 | — | — | US | disclosed |
| US-4155909-A | INSECTICIDES | PHILIP MORRIS INCORPORATED (US) | 1979-05-22 | — | — | US | disclosed |
| EP-0000106-A1 | 2-Alkyl nicotinoids and processes for their production and use | PHILIP MORRIS INCORPORATED (US) | 1978-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11964958-B1 | Vaporizable alkaloid compositions and methods of use thereof | SRM, SCLY, SMOX | CHRM2 7/4885CHRM4 10/4885CHRM5 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.